Voyager Therapeutics (United States)
- Research works
- 102 ▲ 67% vs 2013–17
- Citations
- 1.3k 12.5 per fractional work
- Top-10% rate
- 14.1% record average 16.5%
- Open access
- 37% world 28%
Not ranked overall: Voyager Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.3×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 5.3×
- Arts and Humanities 2.9×
- Immunology and Microbiology 1.9×
- Earth and Planetary Sciences 1.9×
- Social Sciences 1.4×
- Medicine 1.1×
- Physics and Astronomy 1.0×
- Health Professions 0.7×
- Agricultural and Biological Sciences 0.6×
- Economics, Econometrics and Finance 0.6×
- Neuroscience 0.6×
- Computer Science 0.6×
- Engineering 0.3×
- Materials Science 0.2×
- Environmental Science 0.2×
- Psychology 0.1×
Who are the top researchers at Voyager Therapeutics (United States)?
Ranked on the composite score, Toni Talbot lead among researchers whose main affiliation is Voyager Therapeutics (United States).
- 1 Toni Talbot United States · #995,677 worldwide 0 citations · 28 works
Which keywords describe research at Voyager Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Mental Health, Neurodegeneration, Gene Therapy, Primary Care, Health Policy, Nursing Education, Social Determinants of Health and Breast Cancer.
- Glycosylation
- Protein Aggregation
- Alzheimer's Disease
- Dopaminergic Neurons
- Quality Improvement
- Healthcare Workers
- Psychological Health
- Knowledge Management
- Transcriptional Regulation
- Neuroinflammation
- Parkinson's Disease
- Precarious Employment
- Nursing Advocacy
- Viral Vectors
- Mitochondrial Dysfunction
- Breast Cancer
- Nursing Education
- Public Health
- Gene Therapy
- Oxidative Stress
- Mental Health
- Neurodegeneration
- Primary Care
- Health Policy
- Social Determinants of Health
- Genomic Integration
- AAV
- Estrogen
- Political Participation
- Unemployment
- Depression
- Organizational Culture
- Nuclear Receptors
- Performance Improvement
- Cognitive Function
- Continuity of Care
- Amyloid Hypothesis
- Tau Pathology
- Patient Satisfaction
- Tourism
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Mental Health7▲ 6.4×5 topics
- Oxidative Stress6▲ 3.0×14 topics
- Neurodegeneration5▲ 16×6 topics
- Gene Therapy5▲ 18×3 topics
- Primary Care5▲ 11×4 topics
- Public Health5▲ 3.3×5 topics
- Health Policy4▲ 27×2 topics
- Nursing Education4▲ 35×2 topics
- Social Determinants of Health4▲ 17×3 topics
- Breast Cancer4▲ 13×5 topics
- Genomic Integration4▲ 33×2 topics
- Mitochondrial Dysfunction4▲ 9.5×7 topics
- AAV3▲ 51×1 topic
- Viral Vectors3▲ 51×1 topic
- Estrogen3▲ 42×2 topics
- Nursing Advocacy3▲ 169×1 topic
- Political Participation3▲ 38×1 topic
- Precarious Employment3▲ 62×1 topic
- Unemployment3▲ 42×1 topic
- Parkinson's Disease3▲ 13×7 topics
- Depression3▲ 3.8×7 topics
- Neuroinflammation3▲ 10×5 topics
- Organizational Culture3▲ 10×4 topics
- Transcriptional Regulation3▲ 11×3 topics
- Nuclear Receptors3▲ 15×2 topics
- Knowledge Management2▲ 5.4×3 topics
- Performance Improvement2▲ 79×2 topics
- Psychological Health2▲ 120×2 topics
- Cognitive Function2▲ 12×4 topics
- Healthcare Workers2▲ 16×3 topics
- Continuity of Care2▲ 34×1 topic
- Quality Improvement2▲ 10×1 topic
- Amyloid Hypothesis2▲ 39×1 topic
- Dopaminergic Neurons2▲ 32×2 topics
- Tau Pathology2▲ 39×1 topic
- Alzheimer's Disease2▲ 7.0×5 topics
- Patient Satisfaction2▲ 7.8×2 topics
- Protein Aggregation2▲ 25×3 topics
- Tourism2▲ 25×4 topics
- Glycosylation2▲ 8.6×2 topics
Which research topics does Voyager Therapeutics (United States) publish most on?
By volume in 2022–2025: Virus-based gene therapy research, Arctic and Russian Policy Studies, Viral Infectious Diseases and Gene Expression in Insects and Insect Resistance and Genetics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Virus-based gene therapy research Genetics 2 works
- 2 Arctic and Russian Policy Studies Sociology and Political Science 1 works
- 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
- 4 Insect Resistance and Genetics Molecular Biology 1 works
- 5 French Urban and Social Studies Sociology and Political Science 0 works
- 6 French Historical and Cultural Studies History 0 works
- 7 3D Surveying and Cultural Heritage Geology 0 works
- 8 Alzheimer's disease research and treatments Physiology 0 works
- 9 Space exploration and regulation Astronomy and Astrophysics 0 works
- 10 Medicinal Plants and Neuroprotection Complementary and alternative medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Voyager Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 67% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.